Distinct roles for TET family proteins in regulating human erythropoiesis

Blood

Volumn 129, Issue 14, 2017, Pages 2002-2012

  Yan, Hongxia ^a,b   Wang, Yaomei ^a,b   Qu, Xiaoli ^a,b   Li, Jie ^a,b   Hale, John ^a   Huang, Yumin ^a,c   An, Chao ^a   Papoin, Julien ^a   Guo, Xinhua ^a   Chen, Lixiang ^b   Kang, Qiaozhen ^b   Li, Wei ^a   Schulz, Vincent P ^d   Gallagher, Patrick G ^d,e   Hillyer, Christopher D ^a   Mohandas, Narla ^a   An, Xiuli ^a,b,c  

^a NEW YORK BLOOD CENTER   (United States)

^b ZHENGZHOU UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEINS AND BINDING PROTEINS; SHORT HAIRPIN RNA; TEN ELEVEN TRANSLOCATION PROTEIN 1; TEN ELEVEN TRANSLOCATION PROTEIN 2; TEN ELEVEN TRANSLOCATION PROTEIN 3; UNCLASSIFIED DRUG; CD34 ANTIGEN; DIOXYGENASE; DNA BINDING PROTEIN; MIXED FUNCTION OXIDASE; ONCOPROTEIN; TET1 PROTEIN, HUMAN; TET2 PROTEIN, HUMAN; TET3 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; BURST FORMING UNIT E; CELL COUNT; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; COLONY FORMING UNIT; COLONY FORMING UNIT E; CONTROLLED STUDY; DYSERYTHROPOIESIS; ECTOPIC EXPRESSION; ERYTHROBLAST; ERYTHROID CELL; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; FLOW CYTOMETRY; GENE MUTATION; GENE SILENCING; HUMAN; HUMAN CELL; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; CYTOLOGY; GENETICS; HEMATOPOIETIC STEM CELL; METABOLISM; PHYSIOLOGY;

ANTIGENS, CD34; DIOXYGENASES; DNA-BINDING PROTEINS; ERYTHROPOIESIS; GENE KNOCKDOWN TECHNIQUES; HEMATOPOIETIC STEM CELLS; HUMANS; MIXED FUNCTION OXYGENASES; MYELODYSPLASTIC SYNDROMES; PROTO-ONCOGENE PROTEINS;

EID: 85018906608     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2016-08-736587     Document Type: Article

References (47)

1. D'Andrea AD, Lodish HF, Wong GG. Expression cloning of the murine erythropoietin receptor. Cell. 1989;57(2):277-285.
2. Kieran MW, Perkins AC, Orkin SH, Zon LI. Thrombopoietin rescues in vitro erythroid colony formation from mouse embryos lacking the erythropoietin receptor. Proc Natl Acad Sci USA. 1996;93(17):9126-9131.
3. Lin CS, Lim SK, D'Agati V, Costantini F. Differential effects of an erythropoietin receptor gene disruption on primitive and definitive erythropoiesis. Genes Dev. 1996;10(2):154-164.
4. Lin FK, Suggs S, Lin CH, et al. Cloning and expression of the human erythropoietin gene. Proc Natl Acad Sci USA. 1985;82(22):7580-7584.
5. Wu H, Liu X, Jaenisch R, Lodish HF. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell. 1995;83(1):59-67.
6. Pevny L, Lin CS, D'Agati V, Simon MC, Orkin SH, Costantini F. Development of hematopoietic cells lacking transcription factor GATA-1. Development. 1995;121(1):163-172.
7. Siatecka M, Bieker JJ. The multifunctional role of EKLF/KLF1 during erythropoiesis. Blood. 2011;118(8):2044-2054.
8. Mayer W, Niveleau A, Walter J, Fundele R, Haaf T. Demethylation of the zygotic paternal genome. Nature. 2000;403(6769):501-502.
9. Reik W. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature. 2007;447(7143):425-432.
10. Ficz G, Branco MR, Seisenberger S, et al. Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature. 2011;473(7347):398-402.
11. Hackett JA, Sengupta R, Zylicz JJ, et al. Germline DNA demethylation dynamics and imprint erasure through 5-hydroxymethylcytosine. Science. 2013;339(6118):448-452.
12. Okano M, Bell DW, Haber DA, Li E. DNA methyltransferases Dnmt3a and Dnmt3β are essential for de novo methylation and mammalian development. Cell. 1999;99(3):247-257.
13. Goll MG, Bestor TH. Eukaryotic cytosine methyltransferases. Annu Rev Biochem. 2005;74:481-514.
14. Jurkowska RZ, Jurkowski TP, Jeltsch A. Structure and function of mammalian DNA methyltransferases. ChemBioChem. 2011;12(2):206-222.
15. Tahiliani M, Koh KP, Shen Y, et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science. 2009;324(5929):930-935.
16. Koh KP, Yabuuchi A, Rao S, et al. Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells. Cell Stem Cell. 2011;8(2):200-213.
17. Ito S, Shen L, Dai Q, et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science. 2011;333(6047):1300-1303.
18. Surani MA, Hayashi K, Hajkova P. Genetic and epigenetic regulators of pluripotency. Cell. 2007;128(4):747-762.
19. Ito S, D'Alessio AC, Taranova OV, Hong K, Sowers LC, Zhang Y. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature. 2010;466(7310):1129-1133.
20. Delhommeau F, Dupont S, Della Valle V, et al. Mutation in TET2 in myeloid cancers. N Engl J Med. 2009;360(22):2289-2301.
21. Langemeijer S M C, Kuiper RP, Berends M, et al. Acquired mutations in TET2 are common in myelodysplastic syndromes. Nat Genet. 2009;41(7):838-842.
22. Madzo J, Liu H, Rodriguez A, et al. Hydroxymethylation at gene regulatory regions directs stem/early progenitor cell commitment during erythropoiesis. Cell Reports. 2014;6(1):231-244.
23. Pronier E, Almire C, Mokrani H, et al. Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitors. Blood. 2011;118(9):2551-2555.
24. Ge L, Zhang RP, Wan F, et al. TET2 plays an essential role in erythropoiesis by regulating lineage-specific genes via DNA oxidative demethylation in a zebrafish model. Mol Cell Biol. 2014;34(6):989-1002.
25. Gu TP, Guo F, Yang H, et al. The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes. Nature. 2011;477(7366):606-610.
26. Shearstone JR, Pop R, Bock C, Boyle P, Meissner A, Socolovsky M. Global DNA demethylation during mouse erythropoiesis in vivo. Science. 2011;334(6057):799-802.
27. Yu Y, Mo Y, Ebenezer D, et al. High resolution methylome analysis reveals widespread functional hypomethylation during adult human erythropoiesis. J Biol Chem. 2013;288(13):8805-8814.
28. An X, Schulz VP, Li J, et al. Global transcriptome analyses of human and murine terminal erythroid differentiation. Blood. 2014;123(22):3466-3477.
29. Li J, Hale J, Bhagia P, et al. Isolation and transcriptome analyses of human erythroid progenitors: BFU-E and CFU-E. Blood. 2014;124(24):3636-3645.
30. Robinson J, Sieff C, Delia D, Edwards PA, Greaves M. Expression of cell-surface HLA-DR, HLA-ABC and glycophorin during erythroid differentiation. Nature. 1981;289(5793):68-71.
31. Hu J, Liu J, Xue F, et al. Isolation and functional characterization of human erythroblasts at distinct stages: implications for understanding of normal and disordered erythropoiesis in vivo. Blood. 2013;121(16):3246-3253.
32. Salipante SJ, Mealiffe ME, Wechsler J, et al. Mutations in a gene encoding a midbody kelch protein in familial and sporadic classical Hodgkin lymphoma lead to binucleated cells. Proc Natl Acad Sci USA. 2009;106(35):14920-14925.
33. Krem MM, Salipante SJ, Horwitz MS. Mutations in a gene encoding a midbody protein in binucleated Reed-Sternberg cells of Hodgkin lymphoma. Cell Cycle. 2010;9(4):670-675.
34. Krem MM, Luo P, Ing BI, Horwitz MS. The kelch protein KLHDC8B guards against mitotic errors, centrosomal amplification, and chromosomal instability. J Biol Chem. 2012;287(46):39083-39093.
35. Krem MM, Horwitz MS. Mitotic errors, aneuploidy and micronuclei in Hodgkin lymphoma pathogenesis. Commun Integr Biol. 2013;6(3):e23544.
36. Ko M, An J, Rao A. DNA methylation and hydroxymethylation in hematologic differentiation and transformation. Curr Opin Cell Biol. 2015;37:91-101.
37. Wiehle L, Raddatz G, Musch T, et al. Tet1 and Tet2 protect DNA methylation canyons against hypermethylation. Mol Cell Biol. 2015;36(3):452-461.
38. Zhao Z, Chen L, Dawlaty MM, et al. Combined loss of Tet1 and Tet2 promotes B cell, but not myeloid malignancies, in mice. Cell Reports. 2015;13(8):1692-1704.
39. Yang R, Qu C, Zhou Y, et al. Hydrogen sulfide promotes Tet1- and Tet2-mediated Foxp3 demethylation to drive regulatory T cell differentiation and maintain immune homeostasis. Immunity. 2015;43(2):251-263.
40. Costa Y, Ding J, Theunissen TW, et al. NANOGdependent function of TET1 and TET2 in establishment of pluripotency. Nature. 2013;495(7441):370-374.
41. Dussiot M, Maciel TT, Fricot A, et al. An activin receptor IIA ligand trap corrects ineffective erythropoiesis in b-thalassemia. Nat Med. 2014;20(4):398-407.
42. Suragani R N V S, Cadena SM, Cawley SM, et al. Transforming growth factor-b superfamily ligand trap ACE-536 corrects anemia by promoting latestage erythropoiesis. Nat Med. 2014;20(4):408-414.
43. Liu X-L, Yuan J-Y, Zhang J-W, Zhang X-H, Wang R-X. Differential gene expression in human hematopoietic stem cells specified toward erythroid, megakaryocytic, and granulocytic lineage. J Leukoc Biol. 2007;82(4):986-1002.
44. Shi L, Lin Y-H, Sierant MC, et al. Developmental transcriptome analysis of human erythropoiesis. Hum Mol Genet. 2014;23(17):4528-4542.
45. Yang Y, Wang H, Chang K-H, et al. Transcriptome dynamics during human erythroid differentiation and development. Genomics. 2013;102(5-6):431-441.
46. Fontenay-Roupie M, Bouscary D, Guesnu M, et al. Ineffective erythropoiesis in myelodysplastic syndromes: correlation with Fas expression but not with lack of erythropoietin receptor signal transduction. Br J Haematol. 1999;106(2):464-473.
47. Bowen D. What is ineffective erythropoiesis in myelodysplastic syndromes? Leuk Lymphoma. 1995;18(3-4):243-247.